Cell reprogramming for oligodendrocytes: A review of protocols and their applications to disease modeling and cell‐based remyelination therapies
Authors:
Open Access
- 7 February 2023
- journal article
- review article
- Published by Wiley in Journal of Neuroscience Research
- Vol. 101 (6) , 1000-1028
Abstract
Oligodendrocytes are a type of glial cells that produce a lipid‐rich membrane called myelin. Myelin assembles into a sheath and lines neuronal axons in the brain and spinal cord to insulate them. This not only increases the speed and efficiency of nerve signal transduction but also protects the axons from damage and degradation, which could trigger neuronal cell death. Demyelination, which is caused by a loss of myelin and oligodendrocytes, is a prominent feature of many neurological conditions, including Multiple sclerosis (MS), spinal cord injuries (SCI), and leukodystrophies. Demyelination is followed by a time of remyelination mediated by the recruitment of endogenous oligodendrocyte precursor cells, their migration to the injury site, and differentiation into myelin‐producing oligodendrocytes. Unfortunately, endogenous remyelination is not sufficient to overcome demyelination, which explains why there are to date no regenerative‐based treatments for MS, SCI, or leukodystrophies. To better understand the role of oligodendrocytes and develop cell‐based remyelination therapies, human oligodendrocytes have been derived from somatic cells using cell reprogramming. This review will detail the different cell reprogramming methods that have been developed to generate human oligodendrocytes and their applications to disease modeling and cell‐based remyelination therapies. Recent developments in the field have seen the derivation of brain organoids from pluripotent stem cells, and protocols have been devised to incorporate oligodendrocytes within the organoids, which will also be reviewed.Keywords
This publication has 105 references indexed in Scilit:
- High Yields of Oligodendrocyte Lineage Cells from Human Embryonic Stem Cells at Physiological Oxygen Tensions for Evaluation of Translational BiologyStem Cell Reports, 2013
- Generation of oligodendroglial cells by direct lineage conversionNature Biotechnology, 2013
- Transcription factor–mediated reprogramming of fibroblasts to expandable, myelinogenic oligodendrocyte progenitor cellsNature Biotechnology, 2013
- Human iPSC-Derived Oligodendrocyte Progenitor Cells Can Myelinate and Rescue a Mouse Model of Congenital HypomyelinationCell Stem Cell, 2013
- CD140a identifies a population of highly myelinogenic, migration-competent and efficiently engrafting human oligodendrocyte progenitor cellsNature Biotechnology, 2011
- Transplanted Oligodendrocytes and Motoneuron Progenitors Generated from Human Embryonic Stem Cells Promote Locomotor Recovery After Spinal Cord TransectionStem Cells, 2010
- Differentiation of human oligodendrocytes from pluripotent stem cellsNature Protocols, 2009
- Myelin Gene Regulatory Factor Is a Critical Transcriptional Regulator Required for CNS MyelinationCell, 2009
- Genome-scale DNA methylation maps of pluripotent and differentiated cellsNature, 2008
- Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined FactorsCell, 2007